Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay

Purpose: The clinical utility of cell-free DNA (cfDNA) to assess EGFR mutations is increasing. However, there are limited studies determining their clinical validity and utility. The value of cfDNA assays in cancer management remains controversial. Methods: In this study, we first evaluated the anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Qiao-mei, Wang, Lin, Yu, Wen-jun, Qiao, Li-hua, Zhao, Ming-na, Hu, Xiao-meng, Sun, Ya-meng, Ni, Sheng, Xu, Yun-hua, Lou, Jia-tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691702/
https://www.ncbi.nlm.nih.gov/pubmed/31413754
http://dx.doi.org/10.7150/jca.31326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691702/
https://www.ncbi.nlm.nih.gov/pubmed/31413754
http://dx.doi.org/10.7150/jca.31326

Ejemplares similares